Evidence map›Paper›PMID 29142735›Full record

ArticleChemical science2015

Enantioselective palladium(0)-catalyzed intramolecular cyclopropane functionalization: access to dihydroquinolones, dihydroisoquinolones and the BMS-791325 ring system.

J Pedroni, T Saget, P A Donets, N Cramer

Abstract read
In one paragraph

Article in Chemical science, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Intermolecular Enantioselective Nickel-Catalyzed Arylation of Un-Activated C(spAngewandte Chemie (International ed. in English) · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Cyclopropane-FusedJournal of the American Chemical Society · 2022
    Article
  7. Pd(II)-Catalyzed Enantioselective C(spJournal of the American Chemical Society · 2022
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Rhodium-Catalyzed Enantioselective Silylation of Cyclopropyl C-H Bonds.Angewandte Chemie (International ed. in English) · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

J PedroniLaboratory of Asymmetric Catalysis and Synthesis , Institute of Chemical Sciences and Engineering , Ecole Polytechnique Fédérale de Lausanne , EPFL SB ISIC LCSA, BCH 4305 , CH-1015 Lausanne , Switzerland . Email: nicolai.cramer@epfl.ch.
T SagetLaboratory of Asymmetric Catalysis and Synthesis , Institute of Chemical Sciences and Engineering , Ecole Polytechnique Fédérale de Lausanne , EPFL SB ISIC LCSA, BCH 4305 , CH-1015 Lausanne , Switzerland . Email: nicolai.cramer@epfl.ch.
P A DonetsLaboratory of Asymmetric Catalysis and Synthesis , Institute of Chemical Sciences and Engineering , Ecole Polytechnique Fédérale de Lausanne , EPFL SB ISIC LCSA, BCH 4305 , CH-1015 Lausanne , Switzerland . Email: nicolai.cramer@epfl.ch.
N CramerLaboratory of Asymmetric Catalysis and Synthesis , Institute of Chemical Sciences and Engineering , Ecole Polytechnique Fédérale de Lausanne , EPFL SB ISIC LCSA, BCH 4305 , CH-1015 Lausanne , Switzerland . Email: nicolai.cramer@epfl.ch.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Taddol-based phosphoramidite ligands enable enantioselective palladium(0)-catalyzed C-H arylation of cyclopropanes. The cyclized products are obtained in high yields and enantioselectivities. The reported method provides efficient access to a broad range of synthetically attractive cyclopropyl containing dihydroquinolones and dihydroisoquinolones as well as allows for an efficient enantioselective construction of the 7-membered ring of the cyclopropyl indolobenzazepine core of BMS-791325.

Identifiers

PMID29142735
PMCPMC5667185

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.